This study explores the social dynamics in promoting traditional Chinese medicine (tcm) drugs by making them acceptable to biomedical markets. It investigates the Consortium for Globalization of Chinese Medicine (cgcm), an organisation based in Hong Kong in pursuit of advancing tcm, and traces the development of the herbal formula phy906, a Chinese herbal product intensively discussed at the cgcm that has been tested according to the us Food and Drug Administration’s regulation for approval. Departing from accounts on the organisation’s success that focus either on its scientific approach or its leader Yung-chi Cheng, this paper argues that it was the synergy between the cgcm and the pursuit of approval for phy906 that contributed to the regulatory globalisation of tcm. In this process, not only organisations like the cgcm are required to streamline efforts for producing globalised tcm; also researchers are needed who, with cultural commitment, seek for transforming tcm to meet biomedical indications.
bcc Research‘Botanical and Plant-Derived Drugs: Global Markets’2015last accessed on 2 March 2016(Report highlights). url: <http://www.bccresearch.com/market-research/biotechnology/botanical-plant-derived-drugs-report-bio022g.html>
China News Service‘Conversations between Chief Executive Chee-hwa Tung and Legislative Council Members’China.org.cn2001last accessed on 30 October 2014url: <http://big5.china.com.cn/chinese/TCC/65845.htm>
FischerM. M. J.GoodB. J.FischerM. M. J.WillenS. S.DelVecchio GoodM.-J.‘Dr Judah Folkman’s Decalogue and Network Analysis’A Reader in Medical Anthropology: Theoretical Trajectories, Emergent Realities2012ChichesterWiley-Blackwell339344
FurthC.‘The AMS/Paterson Lecture: Becoming Alternative? Modern Transformations of Chinese Medicine in China and in the United States’Canadian Bulletin of Medical History/Bulletin canadien d’histoire de la medicine2011281541
HansonM.‘Is the 2015 Nobel Prize a Turning Point for Traditional Chinese Medicine?’The Conversation2015last accessed on 2 March 2016(6 October 2015), url: <http://theconversation.com/is-the-2015-nobel-prize-a-turning-point-for-traditional-chinese-medicine-48643>
LiuS. H.JiangZ.ChengY. C.‘A Chinese Medicine Formulation, phy906 Can Enhance the Therapeutic Index of CPT-Il and Other Anticancer Drugs against Cancer in Mice’American Association for Cancer Research200141458
LiuS. H.JiangZ.ChengY. C.‘Botanical Activity Relationship in Traditional Chinese Medicine: Studies of phy906 as an Adjuvant Therapy with Cancer Chemotherapeutic Agents’Proceedings of American Association for Cancer Research2002434758
PordiéL.GaudillièreJ. P.‘The Reformulation Regime in Drug Discovery: Revisiting Polyherbals and Property Rights in the Ayurvedic Industry’East Asian Science, Technology and Society: An International Journal201481123
SaifM. W.LansiganF.RutaS.LambL.MezesM.ElligersK.GrantN.JiangZ.LiuS. H.ChengY. C.‘Phase I Study of the Botanical Formulation phy906 with Capecitabine in Advanced Pancreatic and Other Gastrointestinal Malignancies’Phytomedicine2010a17161169
SaifM. W.LiJ.LambL.KaleyK.BussomS.CarboneR.ElligersK.KrishnamoorthyS.LiuS. H.ChengY. C.‘Phase II Study of phy906 plus Capecitabine (CAP) in PTS with Gemcitabine-Refractory Pancreatic Cancer (PC) and Measurement of Cytokines’Journal of Clinical Oncology2010b28e14540(supplement abstract)
SaifM. W.LiJ.LambL.KaleyK.ElligersK.JiangZ.BussomS.LiuS. H.ChengY. C.‘First-in-human Phase II Trial of the Botanical Formulation phy906 with Capecitabine as Second-line Therapy in Patients with Advanced Pancreatic Cancer’Cancer Chemotherapy Pharmacology2014732373380
TengC. M.(鄧哲明)‘Review and Prospects of Taiwan’s tcm research’ [台灣中草藥研究回顧與展望]2014last accessed on 11 August 2015lecture at Graduate Institute of Natural Products, Kaohsiung Medical University, 27 September 2014 (presentation slide), url: <http://nphs.kmu.edu.tw/index.php/zh-TW/公告事項/活動公告/78-台灣中草藥研究回顧與展望-鄧哲明教授主講. ppt slides
United States Food and Drug Administration (fda)‘Guidance for Industry: Botanical Drug Products’2004last accessed on 11 August 2012url: <http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070491.pdf>
YinS. Y.WeiW. C.JianF. Y.YangN. S.‘Therapeutic Applications of Herbal Medicines for Cancer Patients’Evidence-Based Complementary and Alternative Medicine2013last accessed on 2 March 2016Volume 2013Article id 302426, url: <http://dx.doi.org/10.1155/2013/302426>
ZhangX.-C.(张学全)ShenJ.(盛骏)‘The First Three Steps to Turn tcm into Scientific Prescription’ [中药要变成科学处方必须走好头三步]2004last accessed on 19 November 2014Report at www.med66.com, 25 July 25 2004. url: <http://www.med66.com/html/ziliao/07/64/055b16101a3381e4f963bdb30117593a.htm>
Papers include Liu, Jiang, Liddil et al.2000, Liu, Jiang, and Cheng 2001, and Liu, Jiang, and Cheng 2002.
Cheng and Liu2001.
Liu and Cheng2012.
Farrell and Kummar2003.
Saif et al.2010a, 2010b, and 2014.
Liu and Cheng2012, p. 621.
Zhang and Shen2004.
As noted in the 5th meeting, in2006, there were already seven regions, including Taiwan, Hong Kong, Beijing, Shanghai, Guangdong/Guangzhou (广东/广州), Australia/South Pacific, and Canada. Although the definition of these regions is arbitrary, according to the official website of cgcm, there are 11 local chapters. In addition to those mentioned above, they are uk, Europe, Korea, and Chongqing (重庆).